Abstract 320: Association of higher Gleason grade with presence of PTEN deletion in prostatic adenocarcinoma
Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Andrew Evans(University of Dundee), Joan Sweet(University Health Network), Kyu Sang Song(Chungnam National University), Greg Trottier(Princess Margaret Cancer Centre), Olga Ludkovski, Keyue Ding(Ontario Institute for Cancer Research)
Cited by 0
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Review of the current state of whole slide imaging in pathology
|Journal of Pathology Informatics|2011|438
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294